The decision to suspend the trial is viewed as highly questionable, raising disturbing questions about the role that marketing played–especially in light of the fact that Zytiga’s patent is due to expire in 2017.
You can earn up to $5.00 for participating in a research survey. The research study is looking at the importance of information provided in the consent form for the HPV vaccine, Gardasil. The survey has about 30 questions and takes about . . . Continue reading →
About 30 women who participated in a clinical trial have been left hundreds of particles of potentially hazardous metal in their breast by a faulty disk made of tungsten and silicone that was used to shield against radiation exposure.
The Alliance for Human Research Protection (AHRP) has recently obtained further information reaffirming our original concerns and raising new ones about the safety and ethics of a government sponsored clinical trial. Continue reading →
AHRP is concerned about the ethics and safety of human subjects in a blood storage experiment ( RECESS) sponsored
by the National Heart Lung and Blood Institute.
…instead of informed patient consent, doctors too often promoted trial treatments as superior to standard approaches, even when there was no supporting evidence.
The results suggest that the truth may have escaped the usual exclusion criteria. Underlying the commercial success of the new antipsychotics is evidence (usually suppressed) showing that these drugs are both harmful and ineffective even for their approved use.
Continue reading →
"the first-ever randomized, placebo-controlled trial for the alleviation of post-traumatic stress disorder (PTSD)" reports: "we found that it really offered patients no benefits of any symptoms."  Continue reading →
July 26, 2002 Cancer Trials: 60% to 70% of subjects are children – Wall Street Journal The Wall Street Journal reports that there is a shortage of people volunteering to test experimental cancer drugs. “Overall, only 3% to 4% of cancer patients . . . Continue reading →
Commentary by Vera Hassner Sharav February 18, 2002 FYI United States Government Sponsored Genetic Research in Rural China Raises Troubling Ethical Concerns A January 2002 report in China Daily, byXiong Lei, the senior journalist with China Features, Xinhua News Agency(below), raises troubling . . . Continue reading →
Another Child Devloped Cancer: SCID Trials Suspended – ABC Tue, 14 Jan 2003 ABC News reports that the FDA suspended 30 gene therapy trials after a second child developed leukemia. So far, two boys who had undergone the experimental gene therapy treatment . . . Continue reading →
Recent developments in gene transfer research: risk and ethics Mon, 10 Jan 2005 An analysis by Dr. Jonathan Kimmelman, in the British Medical Journal provides an illuminating, clearly articulated discussion about the ethical dilemmas that challenge gene transfer experiments – essentially a . . . Continue reading →